T1	Participants 68 118	in patients with poorly controlled type 2 diabetes
T2	Participants 195 224	patients with type 2 diabetes
T3	Participants 299 324	subjects treated for T2DM
T4	Participants 413 421	Subjects
T5	Participants 772 812	age of the participants was 57 (9)â€‰years
T6	Participants 995 1037	Similar numbers of subjects in both groups
T7	Participants 1168 1198	Subjects treated with glargine
T8	Participants 1673 1701	A greater number of subjects
T9	Participants 1837 1845	subjects
